ACE2 and COVID-19: Likewise, the peripheral accumulation of des−Arg9−bradykinin after ACE2 down-regulation in COVID-19 may provoke “neutrophil infiltration and inflammation, and increased fluid permeability into tissues causing edema” (Seltzer, 2020; Zhang et al., 2021).